Sorafenib as second-line treatment in metastatic renal cell carcinoma: A prospective cohort. Clinical impact of early progression among patients (Pts) with metastatic renal cell carcinoma (mRCC) ...
A multi-institutional team of scientists has developed a free, publicly accessible resource to aid in classification of patient tumor samples based on distinct molecular features identified by The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results